DULCOSOFT 100 ML ORAL SOLUTION is a medical device based macrogol used for the symptomatic treatment of constipation and for softening hard stools.
For warnings, precautions for use and cons-indications, see the instructions for use.
DULCOSOFT 100 ML ORAL SOLUTION is a medical device based macrogol used for the symptomatic treatment of constipation and for softening hard stools.
DULCOSOFT ORAL SOLUTION 100 ML can be mixed with the beverage of your choice, hot or cold (about 150ml), measure the dose using the measuring cup included in the box, the recommended dose of Dulcosoft for adults and children 8 years and older is 20 to 40 ml of solution per day, taken preferably in the morning once. You can adapt the above recommended dosage according to your individual needs: it can range from 1 day to 1 decision taken every two days. The appropriate dose is the lowest dose that helps produce regular soft stools.
10 ml of solution contains 5 g of macrogol 4000. Excipients: potassium sorbate, citric acid, purified water.
250 ml bottle
Warning, the drug is not a product like any other. Read the package leaflet before ordering. Do not leave medicines within reach of children. If symptoms persist, seek the advice of your doctor or pharmacist. Beware of incompatibilities on your current products.
Please tell your online pharmacist ongoing treatment to identify any incompatibilities. The order confirmation form contains a custom message field provided for this purpose.
Click here to find the manual of this drug on the website of the National Agency for Medicines Safety and Health Products.
Pharmacovigilance Reporting an or effect (s) Adverse (s) bound (s) use of a medicament
Oral Solution:
250 ml bottle (ACL 34015 6301731 8 ).
Powder for oral solution:
Box of 10Â bags (ACL 34015 7393250 2 ).
10.5 ml of solution contain 5 g of macrogol 4000. Excipients: potassium sorbate (preservative), citric acid, purified water.
1 sachet of 10 g of powder contains 10 g of macrogol 4000.
DulcoSoft is a medical device whose main component is macrogol® 4000, an osmotic laxative. Macrogol® 4000 has a high water retention capacity. It serves as a support for transporting the liquid (water) and delays the intestinal absorption of water, resulting in an increase in the amount of water in the cone. It softens the hard stools and increases their volume. This leads to speeding up the transit and making the escape easier, offering a feeling of natural relief. The macrogol 4000 has a purely physical mode of action: it is not absorbed by the body and is excreted in unchanged form.
DulcoSoft is prescribed to relieve constipation and soften hard stools.
DulcoSoft has a flavourless taste and can be dissolved (pouch) or mixed directly (drinkable solution) in water or in a cold or hot beverage (approx. 150 ml): glass of water , fruit juice or tea for example.
Unless otherwise prescribed by the physician, the recommended dose is 20 to 40 ml of solution (dose measured using the measuring cup) or 1 to 2 sachets per day (equivalent to 10 to 20 g of macrogol 4000), preferably in a single dose in the morning.
The recommended dose above is to be adapted according to the individual needs. It can go from 1 taken per day to 1 taken every 2 days. The appropriate dose is the lowest to produce regular soft stools.
DulcoSoft usually requires 24 to 72 hours to effect. It should not be taken for more than 15 days. If constipation persists, the cause should be sought.
Do not take a double dose of DulcoSoft if you miss the previous dose.
Excessive doses of DulcoSoft are likely to cause diarrhea, abdominal pain, abdominal distention or vomiting which stop when treatment is discontinued or the dose decreased.
Large fluid losses due to diarrhea or vomiting may require correction of the electrolyte deficiency. Under these circumstances, contact a doctor.
In case of pregnancy or breast-feeding DulcoSoft can be taken, however, it is recommended to seek advice from a physician before using DulcoSoft.
Do not use:
in case of allergy to macrogol  4000 or any of the components,
in children under 8 years of age,
in cases of severe inflammatory bowel disease (such as ulcerative colitis, Crohn's disease) or toxic metabolism (colectasis),
in case of digestive perforation or risk of digestive perforation,
in case of ileus or suspected intestinal obstruction or symptomatic stenosis,
in the case of abdominal pain syndromes of undetermined cause.
As with all laxatives, an organic condition should be avoided before starting treatment.
DulcoSoft should not be used daily over a prolonged period of time without having determined the cause of constipation.
Consult a physician for persistent abdominal pain.
In patients with diarrhea, patients who are subject to disturbance of the hydric or electrolytic balance (eg, elderly, patients with hepatic or renal insufficiency or patients taking diuretics) should be cautious and the electrolyte balance should be monitored.
Allergic reactions (such as shock or anaphylactic reactions, such as angioedema, urticaria, cutaneous rash, hypersensitivity) have been reported in patients taking products containing of the macrogol.
If you experience any of the signs or symptoms described above, stop taking DulcoSoft and consult a physician immediately.
DulcoSoft is suitable for diabetics and patients with low sodium diet.
Generally speaking, the observed side effects have been mild and transient.
In the adult:
Diarrhea, abdominal pain, abdominal distension, nausea, vomiting, fecal incontinence and flatulence.
Rarely, may occur: anaphylactic shock, anaphylactic reaction, ... "Quincke diet, urticaria, cutaneous eruption, hypersensitivity.
In children:
Diarrhea, abdominal pain, abdominal distension, vomiting, nausea and flatulence.
Rarely can occur: anaphylactic shock, anaphylactic reaction, ... angioedema, urticaria, cutaneous eruption, hypersensitivity.
Sachet: contains no gluten.
Keep at a temperature below 25Â ° C.
Oral solution: use within 6 weeks of opening the bottle. Do not refrigerate.
Oral solution: CE marking 0482.
Powder: CE marking 0197.
82, av Raspail. 94250 Gentilly
Medication and pharmacovigilance:
Fax: 01 57 62 06 62
